Topical silver sulphadiazine--a new drug for ocular keratomycosis.
AUTOR(ES)
Mohan, M
RESUMO
The efficacy of silver sulphadiazine in human keratomycosis has not been evaluated so far. Encouraged by the success of an earlier experimental trial, a prospective, controlled, randomised double masked clinical study was designed to evaluate the efficacy of 1% silver sulphadiazine ophthalmic ointment in 20 eyes of mycotic keratitis. Miconazole 1% was used for comparative evaluation in another 20 eyes. Silver sulphadiazine had a higher success rate (80% vs 55%) than miconazole. It had broad antifungal activity and was found to be effective in fusarium keratitis. Absence of side effects, economy, and its efficacy in deeper and extensive lesions were additional advantages. It is concluded from this study that silver sulphadiazine is a safe and effective broad spectrum antifungal agent which can be used for the treatment of human keratomycosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1041404Documentos Relacionados
- Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.
- Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
- Physical methods for topical skin drug delivery: concepts and applications
- HpSS: a new silver staining method for Helicobacter pylori.
- Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: A review
